Acrixolimab
Acrixolimab a humanized IgG4-κ antibody, targeting to PD-1[1][2].
Product Specifications
CAS Number
2506324-29-2
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/acrixolimab.html
Purity
99.9
Solubility
10 mM in DMSO|H2O
Smiles
[Acrixolimab]
Molecular Weight
(145.55 kDa)
References & Citations
[1]Kiratikanon S, et al. Acrixolimab-Induced Radiation Recall Dermatitis with Distinct Features Resembling Erythema Multiforme[J]. Thai Journal of Dermatology, 2023, 39 (2) : 35-38.|[2]Acrixolimab. IMGT/mAb-DB.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
